ORPHA:2062
Progressive non-infectious anterior vertebral fusion
Also known as: Copenhagen syndrome · PAVF
Publications
19
30.1th percentile
Trials
0
Interventional, condition-specific
Researchers
85
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
non-infectious anterior vertebral fusion (PAVF) is an early childhood spinal disorder characterized by the gradual onset of thoracic and/or lumbar spine ankylosis often in conjunction with kyphosis with distinctive radiological features.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0016087
- UMLS:C4304839
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
19 matched papers (12 in last 10 years) Source
- Phenotype characterisedPresent
27 HPO annotations (e.g. Wide mouth; Thin vermilion border; Brachycephaly) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
27
Associated phenotypes · MONDO:0016087
- Wide mouth
- Thin vermilion border
- Brachycephaly
- Round face
- Hypertelorism
Showing 5 of 27 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
19
19 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
19 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
12 in the last 10 years · medium confidence · 30.1th percentile (publications denominator)
Phrase hits: 19 · MeSH hits: 0
Who's working on it?
85
Distinct author names in 19 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Galazo MJ3 papers · 2026
Department of Cell and Molecular Biology, Tulane University, New Orleans, LA, United States.
Papers in Europe PMC - 02Grill F3 papers · 2018Papers in Europe PMC
- 03K C R3 papers · 2026
Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, United States.
Papers in Europe PMC - 04Akumuo M2 papers · 2026
Department of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana.
Papers in Europe PMC - 05Al Kaissi A2 papers · 2008
Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria. ali.alkaissi@osteologie.at
Papers in Europe PMC - 06Blanco-Fernandez X2 papers · 2026
Tulane Brain Institute, Tulane University, New Orleans, LA, United States.
Papers in Europe PMC - 07Chehida FB2 papers · 2018Papers in Europe PMC
- 08Ganger R2 papers · 2018Papers in Europe PMC
- 09Gibson A2 papers · 2016
Spinal Deformity Unit, Department of Spinal Surgery, The Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, HA7 4LP, UK.
Papers in Europe PMC - 10Kantor BL2 papers · 2026
Department of Cell and Molecular Biology, Tulane University, New Orleans, LA, United States.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
medium confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 16 · after dedupe 16 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 16 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (16)
- isrctn·ISRCTN79102999·No longer recruiting·A Phase III study of sepiapterin versus sapropterin in participants with phenylketonuria ≥2 years of age
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN41725621·Recruiting·A study to investigate the safety, tolerability, and exposure of single doses of the study medicine STK-002, in patients with autosomal dominant optic atrophy (ADOA)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13649456·No longer recruiting·A study of three malaria vaccines to prevent the transmission of malaria in adults in Mali: TBVax2
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN51455103·No longer recruiting·A study evaluating the interaction of the body with (pharmacokinetics), clinical activity, and safety of RO6870810 and atezolizumab (PD-L1 Antibody) in participants with advanced ovarian cancer or triple-negative breast cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN19920789·Recruiting·HYPATIA: A prospective randomised controlled trial of hydroxychloroquine to improve pregnancy outcome in women with antiphospholipid antibodies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN92323261·No longer recruiting·SeluDex: an international trial of selumetinib in combination with dexamethasone for the treatment of acute lymphoblastic leukaemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16096154·No longer recruiting·Autologous bone marrow cells in patients with critical limb ischemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN70400953·No longer recruiting·Comparison of precancerous lesions detection between standard colonoscopy and novel balloon colonoscopy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN78449203·No longer recruiting·Adults with Acute Myeloid Leukaemia or High-Risk Myelodysplastic Syndrome (AML19)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16454889·No longer recruiting·Role of Probiotics in recovery of children with Severe Acute Malnutrition
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN86682076·No longer recruiting·Cardiorespiratory fitness, cardiovascular workload and disease among cleaners
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36674014·No longer recruiting·Individualised patient education as supportive lung infection protective technique among patients with acute leukaemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17525991·No longer recruiting·Evaluation of the diagnostic quality of manganese chloride tetrahydrate (CMC-100©) in liver magnetic resonance imaging in patients with known liver metastases: a phase II trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN51173608·No longer recruiting·Evaluation of the diagnostic efficacy of manganese chloride tetrahydrate in liver magnetic resonance imaging in patients with liver metastases: a randomised, parallel group, open-label phase II trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN88423868·No longer recruiting·Evaluation of the diagnostic quality of manganese chloride tetrahydrate (CMC-001©) in liver magnetic resonance imaging in patients with liver metastases in comparison to gadolinium benzyloxypropionictetraacetate (BOPTA): a randomised cross-over phase III trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN08269491·No longer recruiting·Evaluation of the diagnostic efficacy of manganese chloride tetrahydrate (CMC-001©) in magnetic resonance cholangiography in patients with suspected liver lesions: a randomised, parallel group, open-label phase II trial
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Progressive non-infectious anterior vertebral fusion — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Progressive non-infectious anterior vertebral fusion" OR "Copenhagen syndrome"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Progressive non-infectious anterior vertebral fusion" OR "Copenhagen syndrome"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: PAVF
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T18:58:31.943Z
